NCT07393529 2026-04-15
SONATA 2
University of Rochester
Phase NA Recruiting
Clinical Trials
20 trialsNCT06811376 2026-03-25
Pilot Trial of Spiritual Care Interventions for Patients With Cancer
Weill Medical College of Cornell University
Phase NA Recruiting
NCT06656390 2026-03-06
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1/2 Recruiting
NCT07105033 2026-03-02
Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT07382544 2026-02-25
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT07009886 2026-02-19
Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT07343024 2026-02-13
CC N-of-1
Cancer Commons
Recruiting
NCT07133269 2026-02-12
Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients
Singapore General Hospital
Phase NA Recruiting
NCT07269145 2026-01-28
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT04495296 2025-12-19
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
Suzhou Transcenta Therapeutics Co., Ltd.
Phase 1/2 Recruiting
NCT05398484 2025-12-04
Psilocybin Therapy in Advanced Cancer
NYU Langone Health
Phase 2/3 Recruiting
NCT06662760 2025-11-25
Clinical Trial of TQB3002 in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT06092580 2025-09-02
Phase 1 Study of AWT020 in Advanced Cancer
Anwita Biosciences
Phase 1 Recruiting
NCT06963814 2025-07-17
Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors
HC Biopharma Inc.
Phase 1 Recruiting
NCT05276310 2025-06-27
A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy
ImmuneOncia Therapeutics Inc.
Phase 1 Recruiting
NCT06188624 2025-04-25
Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT06616298 2025-04-15
ALIGN
University of Colorado, Denver
Phase NA Recruiting
NCT06707610 2025-03-12
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1 Recruiting
NCT06338683 2024-03-29
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
Qinghai Red Cross Hospital
Phase 3 Recruiting
NCT03503149 2018-04-19
MTB@ZPM
University Hospital Tuebingen
Recruiting